Advertisement

Picture EBD Group BioPharm America 2019 Boston September 600x60px
Document › Details

Uniqure N.V.. (4/29/19). "Press Release: Uniqure Announces First Quarter 2019 Results and Highlights Recent Company Progress". Lexington, MA & Amsterdam.

Organisations Organisation Uniqure N.V. (Nasdaq: QURE)
  Group Uniqure (Group)
  Organisation 2 FDA (US Food and Drug Administration)
  Group United States (govt)
Products Product AMT-061 (hemophilia B gene therapy, Uniqure)
  Product 2 AMT-130 (Huntington’s disease gene therapy, Uniqure)
Persons Person Kapusta, Matthew (Uniqure 201612– CEO before interim CEO before CFO before AngioDynamics + Smith & Nephew Orthopaedics)
  Person 2 Cantor, Maria E. (Uniqure 201606– SVP IR + Communications before Ariad Pharmaceuticals + Genzyme)
     


   
Record changed: 2019-05-23

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

More documents for Uniqure (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px




» top